Page last updated: 2024-11-02

piracetam and Migraine without Aura

piracetam has been researched along with Migraine without Aura in 1 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Migraine without Aura: Recurrent unilateral pulsatile headaches, not preceded or accompanied by an aura, in attacks lasting 4-72 hours. It is characterized by PAIN of moderate to severe intensity; aggravated by physical activity; and associated with NAUSEA and / or PHOTOPHOBIA and PHONOPHOBIA. (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)

Research Excerpts

ExcerptRelevanceReference
" We assessed the effects of a 2-month treatment with topiramate or levetiracetam vs placebo on contingent negative variation (CNV) habituation and amplitude in a cohort of migraine without aura (MO) patients."5.13Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. ( De Stefano, G; de Tommaso, M; Di Claudio, T; Guido, M; Livrea, P; Sardaro, M; Serpino, C; Specchio, LM; Vecchio, E, 2008)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Tommaso, M1
Guido, M1
Sardaro, M1
Serpino, C1
Vecchio, E1
De Stefano, G1
Di Claudio, T1
Specchio, LM1
Livrea, P1

Trials

1 trial available for piracetam and Migraine without Aura

ArticleYear
Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients.
    Neuroscience letters, 2008, Sep-12, Volume: 442, Issue:2

    Topics: Acoustic Stimulation; Adolescent; Adult; Analysis of Variance; Anticonvulsants; Contingent Negative

2008